Colposcopy News and Research

RSS

Guided Therapeutics files PMA for LightTouch Cervical Scanner

Guided Therapeutics, Inc. announced that it filed its completed premarket approval application (PMA) for the LightTouch Cervical Scanner with the U.S. Food and Drug Administration (FDA) for patients at risk for cervical cancer.

28 Sep 2010

Guided Therapeutics receives fund to commercialize LightTouch for cervical cancer detection

Guided Therapeutics, Inc. today announced that it was awarded $1.0 million to fund the second year of a $2.5 million grant from the National Cancer Institute (NCI) announced in 2009.

25 Aug 2010

QIAGEN's digene HPV Test improves cervical cancer control: Study

A study released today "online first" in Cancer Causes & Control demonstrates that human papillomavirus testing, using QIAGEN's digene HPV Test, improved cervical cancer control compared to routine Pap (cytology) testing among 50,000 women across Mexico, the first country in Latin America to implement a national screening program for the high-risk types of HPV that can cause cervical cancer.

From QIAGEN Manchester Limited 13 Jul 2010

HPV DNA testing for precancer, cervical cancer is more sensitive than cytology testing: Study

HPV DNA testing for precancers and cervical cancers is over 50 per cent more sensitive than cytology testing for the same conditions a community-based study in Mexico has revealed. Results of the largest HPV DNA primary screening study ever to be performed in a Latin American country point to the readiness of HPV DNA testing for large-scale implementation in Mexico and are published online today (8 July 2010) in Cancer, Causes and Controls.

9 Jul 2010

Screening for HPV genotypes 16 and 18 helps detect cervical pre-cancer missed by Pap test

Roche today announced that data from the ATHENA (Addressing THE Need for Advanced HPV Diagnostics) U.S. registration trial of over 47,000 women demonstrate that two human papillomavirus genotypes, HPV 16 and HPV 18, can identify those women with cervical pre-cancer missed by cytologic examination with a Papanicolau (Pap) test.

From Roche Sequencing and Life Science 9 Jul 2010

Guided Therapeutics' LightTouch Cervical Scanner demonstrates increased detection of disease over Pap tests

The Guided Therapeutics, Inc. LightTouch™ Cervical Scanner increased detection of significant disease over Pap tests in women seen in a busy private practice setting, according to results of a U.S. Food and Drug Administration pivotal clinical trial presented at the American Society for Colposcopy and Cervical Pathology biennial meeting.

31 Mar 2010

Ikonisys to showcase oncoFISH cervical test at Eurogin 2010 Cervical Cancer Prevention Conference

Ikonisys announced today that they will exhibit their proprietary oncoFISH® cervical test at the Eurogin 2010 Cervical Cancer Prevention Conference held at the Grimaldi Forum in Monte Carlo from February 17-20.

10 Feb 2010

HPV vaccination programs may reduce genital diseases

High-coverage human papillomavirus (HPV) vaccinations among adolescents and young women may result in a rapid reduction of genital warts, cervical cell abnormalities, and diagnostic and therapeutic procedures, researchers report in a new study published online February 5 in the Journal of the National Cancer Institute. Some of these genital abnormalities are precursors of cervical, vulvar, and vaginal cancers.

6 Feb 2010

HPV testing could be used as standard method of cervical screening for women, say Italian scientists

Human papillomavirus (HPV) testing could be used as the standard method of cervical screening for women aged 35 years or older, as it seems to prevent more invasive cases of the disease than cytology screening alone, Italian scientists have said.

20 Jan 2010

AcroMetrix introduces the OptiQual HPV Genotype Panel

AcroMetrix, a leading manufacturer of quality control material for clinical diagnostic and blood testing laboratories, announced today the launch of its OptiQual HPV Genotype Panel. Designed to help clinical laboratories comply with CLIA guidelines for qualitative molecular assays that detect Human Papillomavirus (HPV), this addition to AcroMetrix’s line of women’s health products can assist laboratorians with the validation and verification of their molecular HPV tests.

19 Nov 2009

Results of LightTouch Non-invasive Cervical Cancer Detection Device trial presented

Results of the FDA pivotal clinical trial for the LightTouch™ Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI).

6 Nov 2009

Guided Therapeutics to launch LightTouch non-invasive cancer detection technology at Medica 2009

Guided Therapeutics, Inc. (GT) today announced plans to introduce its LightTouch™ non-invasive cancer detection technology at Medica 2009 in Düsseldorf, Germany November 18 - 20, 2009.

2 Nov 2009

Liquid-based cytology is not better than Pap tests for detecting cervical cancer

A Dutch study that included nearly 90,000 women finds that liquid-based cytology, a commonly used alternative to conventional Pap tests, is not superior to Pap tests for the detection of cervical cancer precursors or cancer, according to a study in the October 28 issue of JAMA.

28 Oct 2009

NCCN updates NCCN Clinical Practice Guidelines in Oncology for Cervical Cancer Screening

The National Comprehensive Cancer Network (NCCN) recently made updates to the NCCN Clinical Practice Guidelines in Oncology(TM) for Cervical Cancer Screening that include a new section providing recommendations for women who have positive results for the HPV High Risk DNA test but negative cervical cytology screen/Pap smears.

15 Oct 2009

Low income women less likely to be screened for cancer in Ontario

Less than half of Ontario women with abnormal Pap tests receive recommended and potentially life-saving follow-up care, according to a new women's health study by researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). What's more, low-income women are less likely to be screened for cancer compared to their high-income counterparts.

20 Aug 2009

Colposcopy News and Research

Guided Therapeutics files PMA for LightTouch Cervical Scanner

Guided Therapeutics receives fund to commercialize LightTouch for cervical cancer detection

QIAGEN's digene HPV Test improves cervical cancer control: Study

HPV DNA testing for precancer, cervical cancer is more sensitive than cytology testing: Study

Screening for HPV genotypes 16 and 18 helps detect cervical pre-cancer missed by Pap test

Guided Therapeutics' LightTouch Cervical Scanner demonstrates increased detection of disease over Pap tests

Ikonisys to showcase oncoFISH cervical test at Eurogin 2010 Cervical Cancer Prevention Conference

HPV vaccination programs may reduce genital diseases

HPV testing could be used as standard method of cervical screening for women, say Italian scientists

AcroMetrix introduces the OptiQual HPV Genotype Panel

Results of LightTouch Non-invasive Cervical Cancer Detection Device trial presented

Guided Therapeutics to launch LightTouch non-invasive cancer detection technology at Medica 2009

Liquid-based cytology is not better than Pap tests for detecting cervical cancer

NCCN updates NCCN Clinical Practice Guidelines in Oncology for Cervical Cancer Screening

Low income women less likely to be screened for cancer in Ontario

PATRICIA trial shows HPV vaccine effective in prevention of cervical lesions

Pap test procedure facts

SpectraScience awarded U.S. patent for methods and apparatus for evaluating image focus

Refined Pap smear test more accurate

Music takes stress out of colposcopy

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News